Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Analgesic

or Botanical

or Sedative-hypnotic

Use the filters below to narrow your results.

Codeine (2)

None (37) · (multiple, generic dominant) (1) · (none, never marketed) (1) · Dalmane (1) · Darvon (1) · Demerol (1) · Dilaudid (1) · Dolophine (1) · Doral (1) · Doriden (1) · Duragesic (1) · Halcion (1) · Hetlioz (1) · Imovane (1) · Lunesta (1) · Mogadon (1) · Nembutal (1) · Nubain (1) · Nucynta (1) · Opana (1) · Placidyl (1) · ProSom (1) · Quaalude (1) · Restoril (1) · Rohypnol (1) · Rozerem (1) · Seconal (1) · Sonata (1) · Stadol (1) · Suboxone (1) · Talwin (1) · THIP (1) · Versed (1) · Vicodin (1) · Xyrem (1)

GABAA positive allosteric modulator (15) · Mu-opioid receptor agonist (4) · Potent mu-opioid receptor agonist (4) · GABAA positive allosteric modulator (non-benzodiazepine) (3) · None (2) · Contains LSA (2) · Contains mescaline (2) · GABAA potentiator and direct activator (2) · Melatonin receptor agonist (2)

Other values:

None (69) · Mild to moderate pain; cough suppression (low-dose). (1) · No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1)

None (69) · Adult: 15–60 mg every 4 hours as needed. (1) · No medical dose. Active recreational doses reported in the 0.5–1.5 mg range (similar potency to alprazolam). (1)

None (69) · Illicit tablets ("bars"), powders, blotter, occasionally solutions. No pharmaceutical product exists. (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

None (69) · 360 mg/day (1) · N/A (never approved) (1)

None (69) · intranasal; rectal and IV reported. (1) · Oral (1) · PO (only formulation marketed in the US). (1) · sublingual (1)

None (69) · 30–60 min (PO) (1) · ~20–40 min PO; faster sublingual/intranasal. (1)

None (69) · 4–6 hours (1) · 6–10 h subjective; full pharmacologic effect considerably longer. (1)

None (69) · 2.5–3 hours (1) · Estimated ~12–17 h (some sources cite up to ~21 h); active metabolites prolong effect. (1)

None (69) · Not formally characterized in humans. (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)

None (69) · Avoid. Benzodiazepines are associated with neonatal sedation, floppy-infant syndrome, and withdrawal; teratogenic signal weak but non-zero. Designer benzo with no safety data, assume worst-case. (1) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1)

None (70) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)

Showing below up to 71 results in range #1 to #71.

7

7-Hydroxymitragynine

A

B

C

D

E

F

G

H

I

Iboga

K

Kava
Kratom

L

M

N

Nalbuphine

O

Oxymorphone

P

Q

Quazepam

R

Ramelteon

S

T

Y

Yopo

Z

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"